One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Classification of Microarray ChipsJanuary 20, 2023A biochip or microarray chip is a microscope slide for the laboratory, usually made of silicon chip, glass, nylon film. It is usually a 2D array (sometimes 3D) with thousands of microwells at defined ...view
What Is The Test For Alcohol Metabolite?March 11, 2024In the realm of diagnostic testing, understanding the body’s processing of substances such as alcohol is crucial for a myriad of applications, from clinical diagnostics to forensic analysis. CapitalB...view
A Brief Analysis of Microfluidic TechnologyApril 16, 2025What is Microfluidic TechnologyMicrofluidic technology is a scientific technology characterized by the precise manipulation of fluids in micro-nano scale spaces. It has the ability to miniaturize the ...view
Microfluidic Chips: What Do You Know?April 4, 2023Microfluidic chip technology integrates the basic operational units of sample preparation, reaction, separation, detection and more involved in biological, chemical and medical analysis processes onto...view